Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer have?
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer has 830 citations in the OpenAlex counts ScholarIQ stores.
When was Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer published?
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer has 2023 year in the ScholarIQ index.
What is the open-access status of Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer?
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer has green oa status in the ScholarIQ index.
What is the DOI of Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer?
The DOI for Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer is on the source record.
What is the PMID of Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer?
The PMID for Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer is on the source record.
What is the OpenAlex record for Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer?
The OpenAlex for Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer is on the source record.